Skip to main content
. 2016 Oct 29;49(5):131–140. doi: 10.1267/ahc.16020

Fig. 6.

Fig. 6.

Immunohistochemical F-actin intensity score in tumor cells evaluated as negative (0), weak (1+), moderate (2+), and strong (3+) for tumors with RhoA overexpression. The x-axis shows the expression status of each target mRNA.